241 related articles for article (PubMed ID: 31645367)
1. Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.
Liu F; Fu J; Bergstrom K; Shan X; McDaniel JM; McGee S; Bai X; Chen W; Xia L
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31645367
[TBL] [Abstract][Full Text] [Related]
2. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
[TBL] [Abstract][Full Text] [Related]
3. Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression.
Brockhausen I; Yang J; Lehotay M; Ogata S; Itzkowitz S
Biol Chem; 2001 Feb; 382(2):219-32. PubMed ID: 11308020
[TBL] [Abstract][Full Text] [Related]
4. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.
Bergstrom K; Fu J; Johansson ME; Liu X; Gao N; Wu Q; Song J; McDaniel JM; McGee S; Chen W; Braun J; Hansson GC; Xia L
Mucosal Immunol; 2017 Jan; 10(1):91-103. PubMed ID: 27143302
[TBL] [Abstract][Full Text] [Related]
5. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.
Holmén Larsson JM; Thomsson KA; Rodríguez-Piñeiro AM; Karlsson H; Hansson GC
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G357-63. PubMed ID: 23832516
[TBL] [Abstract][Full Text] [Related]
6. Loss of intestinal O-glycans promotes spontaneous duodenal tumors.
Gao N; Bergstrom K; Fu J; Xie B; Chen W; Xia L
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G74-83. PubMed ID: 27229122
[TBL] [Abstract][Full Text] [Related]
7. Mucin-Type O-Glycosylation in Gastric Carcinogenesis.
Duarte HO; Freitas D; Gomes C; Gomes J; Magalhães A; Reis CA
Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27409642
[TBL] [Abstract][Full Text] [Related]
8. Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Yamada S; Okamura T; Kobayashi S; Tanaka E; Nakayama J
J Gastroenterol Hepatol; 2015 Oct; 30(10):1478-84. PubMed ID: 25967588
[TBL] [Abstract][Full Text] [Related]
9. Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori.
Rossez Y; Maes E; Lefebvre Darroman T; Gosset P; Ecobichon C; Joncquel Chevalier Curt M; Boneca IG; Michalski JC; Robbe-Masselot C
Glycobiology; 2012 Sep; 22(9):1193-206. PubMed ID: 22522599
[TBL] [Abstract][Full Text] [Related]
10. Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection.
Kobayashi M; Lee H; Nakayama J; Fukuda M
Glycobiology; 2009 May; 19(5):453-61. PubMed ID: 19150806
[TBL] [Abstract][Full Text] [Related]
11. Global Loss of Core 1-Derived
Suzuki R; Nakamura Y; Koiwai R; Fuseya S; Murakami Y; Hagiwara K; Sato T; Takahashi S; Kudo T
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163200
[TBL] [Abstract][Full Text] [Related]
12. Mucin-type O-glycans and their roles in intestinal homeostasis.
Bergstrom KS; Xia L
Glycobiology; 2013 Sep; 23(9):1026-37. PubMed ID: 23752712
[TBL] [Abstract][Full Text] [Related]
13. Cosmc-dependent mucin-type
Stotter BR; Talbot BE; Capen DE; Artelt N; Zeng J; Matsumoto Y; Endlich N; Cummings RD; Schlondorff JS
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F518-F530. PubMed ID: 31904283
[TBL] [Abstract][Full Text] [Related]
14. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases.
Marques T; David L; Reis C; Nogueira A
Pathol Res Pract; 2005; 201(10):665-72. PubMed ID: 16325508
[TBL] [Abstract][Full Text] [Related]
15. [The role of gastric mucins in interactions with Helicobacter pylori].
Radziejewska I
Postepy Hig Med Dosw (Online); 2012 Jan; 66():60-6. PubMed ID: 22371407
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant Expression and Glycosylation of Mucins in Gastric Mucosal Disease].
Zou L; Yang AM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):294-298. PubMed ID: 35538765
[TBL] [Abstract][Full Text] [Related]
17. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
[TBL] [Abstract][Full Text] [Related]
18. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mucin and glycoconjugate expression: from normal epithelium to gastric tumors.
de Bolos C; Real FX; Lopez-Ferrer A
Front Biosci; 2001 Oct; 6():D1256-63. PubMed ID: 11578953
[TBL] [Abstract][Full Text] [Related]
20. Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice.
Song K; Herzog BH; Fu J; Sheng M; Bergstrom K; McDaniel JM; Kondo Y; McGee S; Cai X; Li P; Chen H; Xia L
J Biol Chem; 2015 Aug; 290(33):20159-66. PubMed ID: 26124270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
